US stock futures steady with China trade talks, Q3 earnings in focus
LONDON - Medical technology company Smith+Nephew (LSE:SN, NYSE:SNN) will publish its third quarter 2025 trading report on Thursday, November 6, 2025, at 7:00am GMT, according to a company statement released Thursday.
The trading report will cover the period ended September 27, 2025. Following the release, the company will host a conference call for financial analysts at 8:30am GMT.
Smith+Nephew, a constituent of the FTSE100, specializes in medical technology focused on the repair, regeneration and replacement of soft and hard tissue. The company operates through three global business units: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management.
Founded in Hull, UK, in 1856, Smith+Nephew now has approximately 17,000 employees and operates in more than 100 countries. The company generated annual sales of $5.8 billion in 2024, according to the press release.
The company’s trading update is expected to provide insights into its financial performance during the third quarter of the fiscal year.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.